Kedrion Biopharma announced today that it has received FDA approval for QIVIGY immune globulin intravenous (human)-kthm 10% ...
The FDA has approved Qivigy (immune globulin intravenous, human-kthm) 10% solution for the treatment of adults with primary humoral immunodeficiency.
Approved for earliest symptomatic stages of disease, demonstrating significant slowing of cognitive and functional decline Only therapy with evidence to ...
As we mark the first anniversary of flooding from Hurricane Helene that devastated parts of North Carolina, the anesthesia ...
Only patients who received rituximab, ipilimumab plus nivolumab, and trastuzumab plus pertuzumab had infusion-related reactions in the real-world cohort.
Paulick Report on MSN
Study: Rate Of Penicillin Administration Affects A Horse's Arterial Blood Pressure
Sudden drops in blood pressure during surgery can be risky; this study suggests that slowing down the penicillin injection ...
In September 2024, Hurricane Helene damaged a Baxter International plant in Marion, N.C., that produces 60% of the U.S.’s IV fluid products, disrupting ASCs and other healthcare facilities across the ...
Dr. Viviane Bunin also is boosting patient satisfaction and getting reimbursed for this new technology: Of 66 HRV tests to date, 78.8% were reimbursed by insurers. "Patient feedback has been ...
Cystatin C is an emerging biomarker that enhances kidney function assessment accuracy, particularly in hospitalized patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback